• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

small-molecule cancer drug

	Next higher product group	cancer drug

Record changed: 2022-05-03

Advertisement

More documents for small-molecule cancer drug

• [1] Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo....
• [2] Blueprint Medicines Corporation. (11/29/21). "Press Release: Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics". Cambridge, MA & San Diego, CA....
• [3] Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel....
• [4] Tyra Biosciences, Inc.. (1/10/20). "Press Release: Tyra Biosciences Raises $50m to Develop Therapies Targeting Acquired Resistance in Oncology". Carlsbad, CA....
• [5] Civetta Therapeutics, LLC. (12/4/19). "Press Release: Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins Civetta Therapeutics is a Deerfield Founded and Funded Comp...
• [6] SpringWorks Therapeutics, Inc.. (9/12/19). "Press Release: SpringWorks Therapeutics Announces Pricing Of Initial Public Offering". Stamford, CT....
• [7] Boehringer Ingelheim. (11/15/18). "Press Release: Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies". Cambridge, MA & Ingelheim....
• [8] Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY....
• [9] Revolution Medicines, Inc.. (7/18/18). "Press Release: Sanofi and Revolution Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers". Cambridge, MA & Redwood City, CA....
• [10] G1 Therapeutics, Inc.. (7/9/18). "Press Release: G1 Therapeutics Expands Executive Leadership Team with Appointment of John Demaree as Chief Commercial Officer and Stillman Hanson as General Counsel". Research Triangle Park, NC....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.